FDA inspection
Frontida BioPharm LLC: FDA inspection ending Jul 20, 2017
FDA inspection 1027425 · No Action Indicated (NAI) · Philadelphia, PA
Key facts
| Inspection ID | 1027425 |
|---|---|
| Firm | Frontida BioPharm LLC |
| FEI number | 3004464206 |
| Address | 1100 Orthodox St |
| City | Philadelphia |
| State | PA |
| ZIP | 19124 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Jul 20, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data